Grifols, the Spanish plasma products company, pauses plasma collections at multiple clinics in Canada following the deaths of two plasma donors. The New York Times reports Grifols ends collections temporarily at 17 clinics. Global News says the company is pausing all collection in Canada and has communicated the decision to Health Canada.
Grifols’ explanation centers on concerns it describes as “unfounded attention” related to its blood plasma business in Canada. Both outlets report that the company presents the pause as voluntary and temporary. The reports describe the decision as a response to scrutiny that follows the two deaths, while the specific circumstances of the fatalities and any related findings are not detailed in the provided accounts. Health Canada’s role in receiving the notification is noted, but broader regulatory actions or investigations beyond the pause are not described here.
